InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease

● . . | --- | --- | |-------------------------------------------------------------------------------------------|-------| | | | | InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of | | | Neurodegenerative Conditions Including | | October 28, 2024 7:30 AM EDT | Source: InMed Pharmaceuticals Vancouver, British Columbia--(Newsfile Corp. - October 28, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing ...